Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact | JACC: CardioOncology
About this episode
This study of 801 multiple myeloma patients found that atrial fibrillation occurred in 5.5% within 90 days after autologous stem cell transplantation—nearly double previously reported rates—indicating disease‑specific risks. AF strongly predicted mortality from non‑relapse causes and may serve as a marker of physiological vulnerability, emphasizing the value of expanded pre‑transplant cardiac assessment and monitoring.
Get every episode summarized
Each time JACC Specialty Journals publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from JACC Specialty Journals
Development of a Predictive Tool in Patients With High Pretest Probability for T...
JACC Specialty Journals
Valvular Heart Diseases in Swedish Males and Females: A National Cohort Study |...
JACC Specialty Journals
Cardiovascular-Kidney-Metabolic Syndrome and Life Expectancy in U.S. Adults | JA...
JACC Specialty Journals
Remote Management of Patients With Heart Failure in Medically Underserved Areas...
JACC Specialty Journals